warnings and cautions
5 WARNINGS AND PRECAUTIONS 5.1 Worsening Cardiac Function Use in patients with impaired cardiac response may worsen cardiac output.
VASOPRESSIN
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- VASOPRESSIN
- Generic name
- VASOPRESSIN
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 7ae1c8c9-7d75-55a8-e053-2991aa0af05b
- SPL ID
- cfc4383a-4c3c-69a0-e053-2a95a90a268a
- Version
- 6
- Effective date
- 2021-11-01
- Source export date
- 2026-10-27
- Source partition
- 3
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-27/d7629e6f844435cfe6cb0cf8c5341c46775ea16c5af42c77a22a2ffe820a2cd2/drug-label-0003-of-0014.json.zip
- Source manifest SHA-256
- 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
- Import run
- 20261027T193451Z
- Imported at
- 2026-10-27 19:48:45
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 204485 | derived:openfda.application_number |
| application number | NDA204485 | openfda.application_number | |
| brand name | VASOPRESSIN | openfda.brand_name | |
| generic name | VASOPRESSIN | openfda.generic_name | |
| manufacturer name | HF Acquisition Co LLC, DBA HealthFirst | openfda.manufacturer_name | |
| ndc | package | 51662-1314-2 | openfda.package_ndc |
| ndc | package | 51662-1314-1 | openfda.package_ndc |
| ndc | product | 51662-1314 | openfda.product_ndc |
| ndc11 | package | 51662131402 | derived:openfda.package_ndc |
| ndc11 | package | 51662131401 | derived:openfda.package_ndc |
| rxcui | 2103182 | openfda.rxcui | |
| spl id | cfc4383a-4c3c-69a0-e053-2a95a90a268a | id | |
| spl set id | 7ae1c8c9-7d75-55a8-e053-2991aa0af05b | set_id | |
| unii | Y87Y826H08 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS The following adverse reactions associated with the use of vasopressin were identified in the literature. Because these reactions are reported voluntarily from a population of uncertain size, it is not possible to estimate their frequency reliably or to establish a causal relationship to drug exposure. Bleeding/lymphatic system disorders: Hemorrhagic shock, decreased platelets, intractable bleeding Cardiac disorders: Right heart failure, atrial fibrillation, bradycardia, myocardial ischemia Gastrointestinal disorders: Mesenteric ischemia Hepatobiliary: Increased bilirubin levels Renal/urinary disorders: Acute renal insufficiency Vascular disorders: Distal limb ischemia Metabolic: Hyponatremia Skin: Ischemic lesions
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.